Abstract:Ionizable lipid nanoparticles (LNPs) are the most clinically advanced nano-delivery system for therapeutic nucleic acids. The great effort put in the development of ionizable lipids with increased in vivo potency brought LNPs from the laboratory benches to the FDA approval of patisiran in 2018 and the ongoing clinical trials for mRNA-based vaccines against SARS-CoV-2. Despite these success stories, several challenges remain in RNA delivery, including what is known as "endosomal escape." Reaching the cytosol is mandatory for unleashing the therapeutic activity of RNA molecules, as their accumulation in other intracellular compartments would simply result in efficacy loss. In LNPs, the ability of ionizable lipids to form destabilizing non-bilayer structures at acidic pH is recognized as the key for endosomal escape and RNA cytosolic delivery. This is motivating a surge in studies aiming at designing novel ionizable lipids with improved biodegradation and safety profiles. In this work, we describe the journey of RNA-loaded LNPs across multiple intracellular barriers, from the extracellular space to the cytosol. In silico molecular dynamics modeling, in vitro high-resolution microscopy analyses, and in vivo imaging data are systematically reviewed to distill out the regulating mechanisms underlying the endosomal escape of RNA. Finally, a comparison with strategies employed by enveloped viruses to deliver their genetic material into cells is also presented. The combination of a multidisciplinary analytical toolkit for endosomal escape quantification and a nature-inspired design could foster the development of future LNPs with improved cytosolic delivery of nucleic acids.

An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids

Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s.

Cell-Penetrating Peptides as Keys to Endosomal Escape and Intracellular Trafficking in Nanomedicine Delivery

Achieving Endo/Lysosomal Escape Using Smart Nanosystems for Efficient Cellular Delivery

Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape

Recent progress in nanomedicine-mediated cytosolic delivery

Transporting Carriers for Intracellular Targeting Delivery Via Non-Endocytic Uptake Pathways

Endolysosomal trapping of therapeutics and endosomal escape strategies

Direct cytosolic delivery of DNA by creating fast closable holes in the cell membrane

Beyond chloroquine: Cationic amphiphilic drugs as endosomal escape enhancers for nucleic acid therapeutics

Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles

Advanced strategies for overcoming endosomal/lysosomal barrier in nanodrug delivery

Acid-Sensitive Surfactants Enhance the Delivery of Nucleic Acids

Nanocarrier‐Mediated Cytosolic Delivery of Biopharmaceuticals

Endosomal escape: A bottleneck for LNP-mediated therapeutics

Intracellular delivery strategies using membrane-interacting peptides and proteins

Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome

Nanocarriers for Protein Delivery to the Cytosol: Assessing the Endosomal Escape of Poly(Lactide-co-Glycolide)-Poly(Ethylene Imine) Nanoparticles

Curb Challenges of the "trojan Horse" Approach: Smart Strategies in Achieving Effective Yet Safe Cell-Penetrating Peptide-Based Drug Delivery.

Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery

Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies